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Background. Delay in pulmonary tuberculosis (PTB) diagnosis is one of the major factors that aﬀect outcome and threatens
continued spread of tuberculosis. This study aimed at determining factors associated with delayed PTB diagnosis among human
immunodeficiency virus (HIV) infected individuals. Methods. A retrospective observational study was done using clinic records of
HIV-infected PTB suspects attending an HIV/AIDS clinic at Tintswalo rural hospital in South Africa (SA) between January 2006
and December 2007. Using routine clinic registers, 480 records were identified. Results. PTB diagnosis delay was found among
77/176 (43.8%) of the patients diagnosed with PTB. The mean delay of PTB diagnosis was 170.6 days; diagnosis delay ranged
1–30 days in 27 (35.1%) patients, 31–180 days in 24 (33.8%) patients; 24 (31.2%) patients remained undiagnosed for ≥180 days.
Independent factors associated with delayed diagnosis were: older age >40 years (Odds Ratio (OR) 3.43, 95% CI 1.45–8.08) and
virological failure (OR 2.72, 95% CI 1.09–6.74). Conclusion. There is a considerable delayed PTB diagnosis among HIV-infected
patients in rural SA. Older patients as well as patients with high viral load are at a higher risk of PTB diagnosis delay. Therefore
eﬀorts to reduce PTB diagnosis delay need to emphasised.
1. Background
An estimated one-third of the world’s population is infected
with tuberculosis (TB) [1]. The human immunodeficiency
virus (HIV) pandemic has resulted in dramatic increases in
TB case notification rates, particularly in resource-limited
settings [2]. This is because people living with HIV have
a much greater risk of developing active TB than HIV-
uninfected individuals [3]. South Africa is one of the
countries most heavily aﬀected by the dual HIV and TB
epidemics [4], with an estimated 31% of all global TB
cases occurring among HIV-positive individuals [5]. For
example, in Gugulethu, a township in Cape Town, over
half of antiretroviral therapy (ART) clinic attendees had
previously been treated for TB, one-quarter were diagnosed
with active TB, and a further 10% developed TB during the
first year following initiation onto lifelong ART [6].
In resource-limited settings, where the majority of HIV-
TB cases occur, TB diagnostics are frequently limited to
sputum smear microscopy, despite the increased likeli-
hood of smear negative disease among immunosuppressed
patients [7]. This scenario complicates TB diagnosis and
frequently results in delay in TB diagnosis in HIV-infected
patients [8]. This delayed detection often leads to increased
mortality and treatment complications for patients [9]. In
addition, undiagnosed TB in patients starting ART may
result in symptomatic immune reconstitution inflammatory
syndrome during early ART phase because of unmasking
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of TB disease by ART [10]. We have previously reported
on high mortality due to TB among ART initiators in this
community [11]. Reducing delays in PTB diagnosis could
improve patients’ health outcomes and minimise public risk
of exposure to TB in the community. The purpose of this
study was to investigate factors associated with the delay in
TB diagnosis amongHIV patients following entry into public
sector HIV services in rural South Africa.
2. Methods
2.1. Study Setting. This study was conducted at Rixile
Clinic, a dedicated nongovernmental-organisation-(NGO-)
supported, rural HIV clinic situated at Tintswalo hospital
in Bushbuckridge, Mpumalanga, South Africa. Three HIV-
trained doctors and six primary health care nurses provide
comprehensive care for HIV patients at the clinic, including
provision of ART, and screening for and management of TB,
opportunistic infections, and sexually transmitted infections.
The clinic was accredited for provision of ART in October
2005. Since then more than 2,000 individuals have been
initiated on ART. Bushbuckridge is a densely populated rural
area with a population of approximately 600,000 people
living in 133 villages. The region is one of 13 rural nodal areas
of extreme poverty in South Africa.
2.2. Study Design. This was a retrospective cohort study of
PTB suspects at Rixile Clinic. Data were extracted from the
ART clinic records of patients identified as PTB suspects
from the PTB suspects register over a two-year period from
January 2006 to December 2007.
2.3. Study Population. The study population was comprised
of adults (18 years and older) at the time of identification as a
PTB suspect and with confirmed HIV infection. All patients
had attended the Rixile clinic at least once. PTB suspects were
defined as patients who were provided with sputum jars for
Acid-Fast Bacilli screening for PTB.
2.4. Data Collection and Management. Trained research
assistants extracted data from the PTB suspects register and
from patients’ ART clinic medical records using a structured
data collection tool. Data were abstracted on the following
variables: sociodemographic factors, presenting symptoms,
timing, and results of TB investigations, diagnosis category,
date and regimen of TB treatment initiated, and details of
HIV treatment, including ART initiation. Data were double-
entered into Epi info version 3.5.1 (CDC, Atlanta, USA).
Statistical analyses were conducted using STATA version 11
(Statacorp, College Station, USA).
2.5. Definition of TB Diagnosis Delay. TB diagnostic delay
was defined as any diagnosis taking longer than 56 days
from the time of requesting the first sputum examination.
Although this definition is unconventional, it allows for
the time required to complete all diagnostic examinations,
including sputum culture, which is routinely requested
among HIV-positive TB suspects with smear-negative results
attending services at Rixile HIV clinic [12].
2.6. Statistical Analysis. Frequency distributions were used to
describe categorical variables, and medians and interquartile
ranges were used for continuous variables. The dependent
variable diagnosis delay was categorized as a dichotomous
variable (delay or nodelay). Bivariate associations were
described using Chi-square tests. Variables that demon-
strated significant association (P ≤ 0.1) with TB diagnosis
delay were entered into a multivariate Cox proportional
hazards regression model.
2.7. Ethical Consideration. Ethical approval for the study
was obtained from the University of Witwatersrand Human
Research Ethics Committee. Individual informed consent
was not undertaken as the study used routinely collected
clinic data.
3. Results
In the two-year study period, 630 individuals were identified
as PTB suspects and recorded in the PTB suspect register.
Sixty-two were excluded for the following reasons: 4 were
younger than 18 years old, 42 did not return their sputum
jars and did not attend any subsequent review, 1 had
extra pulmonary TB, and there was no information on the
outcome of TB diagnosis for 15 patients. Eighty-five patients’
medical records were missing and 31 were duplicates. Thus, a
total of 452 PTB suspects were included in the study. Figure 1
summarizes the patients’ inclusion cascade.
The demographic information of the 452 patients includ-
ed in the preliminary analysis is summarized in Table 1.
The ages of the patients ranged from 23 to 96 years old
with a median age of 41 years (interquartile range (IQR) =
35–49). Seventy percent (316/452) of the participants were
women; 175/446 (39.2%) were notmarried, 191/447 (42.7%)
had attended primary school only, and more than half
403/449 (89.7%) were unemployed.
3.1. PTB Cases Diagnosed. Of the 452 PTB suspects, 162
(35.8%) PTB cases were diagnosed. Of those diagnosed with
PTB, 40 (24.7%) were diagnosed on the basis of sputum
smear positivity, 84 (51.9%) through positive sputum cul-
ture, and 38 (23.5%) through chest radiograph.
3.2. Outcomes of PTB Treatment. Out of the 162 patients
diagnosed with PTB and started on TB treatment, 86 (53.1%)
completed treatment, 14 (8.6%) died, 34 (21.0%) were lost to
follow up, and 28 (17.3%) were still on treatment at time of
data extraction.
3.3. Delay in Diagnosis of PTB. The median delay from
presentation with PTB symptoms to PTB diagnosis was 55
days (IQR = 20–302). Delay in diagnosis of PTB of more
than 56 days was observed among 78 (48.2%) of the 162
patients diagnosed with PTB. The overall delay was 57 to 86
days in 27 (34.6%), 87 to 223 days in 26 (33.3%), and >236
Tuberculosis Research and Treatment 3
record s traced 
452 patients
175 with PTB
162 patients
31 duplicated 
records
277 diagnosed  as 
not having PTB
78 with diagnostic 
delay
84 without 
diagnostic delay
630 PTB suspects
4 children, 1 extra-
pulmonary TB, 58
no AFB investigations
85 missing records
8 errors recoding dates, 2
diagnosis >4 years later,
3 missing dates
483-patient
Figure 1: Cohort Flowchart ∗∗4 younger than 18 years, 1 with
extrapulmonary TB, 58 with no AFB investigation requested. ∗∗∗31
observations were duplicates ∗∗∗∗8 with negative time interval to
TB diagnosis, 2 with time interval to TB diagnosis >4 years, 3 with
missing TB diagnosis date.
days in 25 (32.1%) of the patients diagnosed with PTB. The
diagnosis was made by clinical history plus chest X-ray for
19 of the 78 (24.7%) and by sputum smear microscopy for
12 (15.4%) The majority of patients with diagnostic delay
had their diagnosis made by sputum culture 47/78 (60.3%)
(Table 2).
3.4. Factors Associated with TB Diagnosis Delay. Univariate
analysis showed patient’s age (P = 0.006), method of TB
diagnosis (P = 0.025), detectable HIV viral load (P = 0.025),
and ART use at the time of PTB diagnosis (P ≤ 0.001), to
be significantly associated with TB diagnosis delay (Table 3).
Age, viral load and ART use at the time of PTB diagnosis
remained statistically significant in the multivariate analysis.
Patients who were older than 40 years had a 1.57 times
greater risk of TB diagnostic delay than those aged 18–40
years. The risk of TB diagnostic delay was 1.89 times greater
in those with HIV viral load ≥400 copies/mL than patients
with HIV viral load ≤400 copies/mL; however the observed
association was not statistically significant P = 0.06. Those
who were on ART at the time of PTB diagnosis were 51% less
Table 1: Socioeconomic characteristics of study participants.
Characteristic N (%)
Marital status
Divorced 81 18.2
Married 131 29.4
Never married 175 39.2
Widowed 59 13.2
Total 446 100.0
Education level
No education 90 20.1
Primary 191 42.8
Secondary 152 34.0
Tertiary 14 3.1
Total 447 100.0
Occupation status
Salaried worker 46 10.3
Unemployed and willing to work 142 31.6
Unemployed and not willing to work 261 58.1
Total 449 100.0
Cigarette smoker
No 359 80.7
Yes 86 19.3
Total 445 100.0
Alcohol drinker
No 355 79.9
Yes 89 20.1
Total 444 100.0
Main material walls of house
Block cement 229 51.0
Brick 115 25.6
Mud 105 23.4
Total 449 100.0
People in households
1 to 5 239 53.1
6 to 10 187 41.6
>10 24 5.3
Total 450 100.0
N: number of study participants in each variable.
likely to have experienced diagnostic delay than those who
were not on ART (Table 4).
4. Discussion
A large proportion of PTB patients experienced diagnostic
delays of greater than 56 days. These findings have important
implications for informing current Stop-TB eﬀorts aimed at
reducing global TB incidence and mortality. TB diagnosis
delay was associated with viral load≥400 copies/mL. Delayed
detection leads to patients presenting with advanced TB
which promotes HIV/AIDS disease progression by acceler-
ating viral multiplication [13].
TB diagnostic delay was significantly associated with
patient’s age. Older patients (>40 years) were at a much
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Table 2: Diagnosis delay duration by method of diagnosis.
Method of TB diagnosis 57 to 86 days
delay ∗∗N (%)
87 to 236 days
delay ∗∗N (%)
>236 days delay
∗∗N (%)
Total Number
(%)
P value
Clinical history and chest X-ray 4 (15.3) 5 (19.2) 10 (40) 19 (24.7)
0.016
Sputum smear positive 3 (11.5) 2 (7.7) 7 (28) 12 (15.6)
Sputum culture 20 (74.1) 19 (73.1) 8 (32) 47 (60.3)
Total 27 (100) 26 (100) 25 (100) 78 (100)
∗∗
N: number of TB patients diagnosed within each time duration.
Table 3: Comparison of sociodemographic and clinical factors of participants with TB diagnosis delay.
Characteristic Diagnosis delay number (%) No delay number (%) P value
Patient age
18 to 40 years 33 (42.9) 54 (64.3)
0.006∗∗
>40 years 44 (57.1) 30 (35.7)
Sex
Female 49 (62.9) 58 (69.0)
0.403
Male 29 (37.1) 26 (31.0)
Marital status
Divorced 13 (16.9) 13 (15.4)
0.592
Married 25 (32.5) 21 (25.0)
Never married 27 (35.1) 38 (45.2)
Widowed 12 (15.5) 12 (14.3)
Occupation status
Salaried worker 9 (11.7) 7 (8.3)
0.538
Unemployed and willing to work 21 (27.3) 29 (34.5)
Unemployed and not willing to work 47 (61.0) 48 (57.2)
Smoke cigarette
No 57 (74.0) 66 (78.6)
0.410
Yes 20 (26.0) 18 (21.4)
Alcohol drinking
No 57 (74.0) 65 (79.3)
0.434
Yes 20 (26.0) 17 (20.7)
Education level
No education 16 (20.8) 14 (16.7)
0.320
Primary 37 (48.0) 33 (39.2)
Secondary 23 (29.9) 33 (39.3)
Tertiary 1 (1.3) 4 (4.8)
Main material walls of house
Block cement 38 (49.3) 47 (56.0)
0.377Brick 19 (24.7) 22 (26.1)
Mud 20 (26.0) 15 (17.9)
Method of TB diagnosis
Clinical history and CXR 19 (24.7) 19 (22.9)
0.025∗∗Sputum AFB 12 (15.6) 28 (33.7)
Sputum culture 46 (59.7) 36 (43.4)
WHO-HIV clinical stage
1 2 (3.6) 2 (2.9)
1.000
2 9 (16.4) 16 (23.5)
3 42 (76.4) 44 (64.8)
4 2 (3.6) 6 (8.8)
CD4 count (cells/mm3)
<50 4 (6.9) 1 (1.8)
0.19350–200 15 (25.9) 10 (17.9)
>200 39 (67.2) 45 (80.3)
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Table 3: Continued.
Characteristic Diagnosis delay number (%) No delay number (%) P value
Viral load (copies/mL)
≤400 31 (60.8) 39 (81.3)
0.025∗∗
>400 20 (39.2) 9 (18.7)
BMI (Kg/m2)
Underweight 16 (25.4) 15 (22.4)
0.828
Normal weight 34 (53.9) 38 (56.7)
Overweight 12 (19.0) 11 (16.4)
Obese 1 (1.5) 3 (4.5)
ART use at PTB diagnosis
No 38 (50.0) 62 (77.5) ≤0.001∗∗
Yes 38 (50.0) 18 (22.5)
TB treatment outcome
Completed treatment 41 (52.5) 45 (53.6)
0.640
Died 7 (9.1) 7 (8.3)
Lost to follow up 14 (17.9) 20 (23.8)
Still on treatment 16 (20.5) 12 (14.3)
∗∗
P value ≤ 0.05.
Table 4: Univariate and multivariate Cox proportional hazards regression analysis.
Characteristic Univariate HR (95% CI) P-value Multivariate HR (95% CI) P value
Patient age
18 to 40 years 1 1
>40 years 1.8 (0.53–1.32) 0.05 1.57 (0.25–0.90) 0.02
Sex
Female 1
Male 1.26 (0.79–2.03) 0.33 — —
Education level
No education 1
Primary 2.62 (1.28–5.34) 0.25
Secondary 7.09 (0.87–7.56) 0.17
Tertiary 1.54 (0.79–2.95) 0.19
Method of TB diagnosis
History and CXR 1
Smear positive 0.83 (0.48–2.14) 0.95 — —
Sputum culture positive 2.09 (1.19–3.65) 0.09
Viral load (copies/mL)
<400 1 1
>400 2.3 (0.87–1.56) 0.07 1.89 (0.74–1.63) 0.06
CD4 Count (cells/mm3)
<50 1
50–200 0.56 (0.18–1.72) 0.31 — —
>200 0.64 (0.20–1.64) 0.42
ART use at PTB diagnosis
No 1 1
Yes 0.82 (1.05–1.3) 0.04 0.49 (0.36–0.97) 0.04
TB treatment outcome
Completed treatment 1
Died 2.42 (1.07–5.47) 0.03 — —
Lost to follow-up 0.92 (0.49–1.73) 0.81
Still on treatment 0.79 (0.43–1.46) 0.45
HR: hazard ratio; CI: confidence interval.
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higher risk of TB diagnostic delay compared with those
younger than 40 years. This is likely to be due to coexisting
medical conditions in the elderly persons such as heart
diseases and chronic chest problems, all of which may
contribute to the diﬃculty of diagnosing TB and can thus
result in delayed diagnosis and treatment [14, 15].
The majority of patients with diagnostic delay in this
study (60.3%) were diagnosed with PTB by sputum culture.
This may be because the study was conducted among HIV-
infected patients, and studies have reported reduced diag-
nostic sensitivity of sputum smears and chest radiography
in HIV infected patients [7]. Given the high percentage of
patients diagnosed by TB culture, these findings support the
practice of regular sputum culture tests to confirm sputum
negative smears in ART clinics. Those who were not on ART
at the time of PTB diagnosis were more likely to have delayed
diagnosis than those who were on ART. ART unmasks TB
in HIV-infected patients with subclinical disease making it
easier to detect and diagnose [10].
There are several factors that have been reported from
previous studies that influences delay in TB diagnosis.
These could be patient, clinician, or health system related.
Patient-related factors include choice of health care provider,
stigma, alcoholism, substance abuse, general state of poor
health, tobacco smoking, and chronic cough with blood-
stained sputum [16–26]. Clinician-related factors include:
poor training of clinical personnel in TB diagnosis, low level
of TB awareness among private practitioners, and lack of
knowledge of TB diagnosis among traditional healers [20, 22,
24–29]. Health system factors that play a role in delayed TB
diagnosis include lack of diagnostic facilities and low access
to health care services [26, 30].
High viral load is a clinical indicator of declining
immunological function of an HIV-infected individual
which makes them to be at higher risk of developing active
TB. In this era of ongoing HIV epidemic, diagnosis and
clinical management of active TB poses a major challenge in
patients with dual infection [31]. Due to immunosuppres-
sion, there is lack of pulmonary cavitations resulting in low
bacillary concentration in sputum giving rise to high rate
of negative sputum smear for AFB as well as negative chest
radiographic findings. This has led to an over reliance of TB
diagnosis through sputum culture which is an expensive and
slow diagnostic method [32, 33]. This could be the reason
why our study showed that a positive relationship exists
between diagnostic delay and decline in immune function
(viral load >400 copies/mL).
In considering the findings of this study it is important
to bear in mind the following limitations: firstly, as this
cohort was recruited from an ART clinic, they may have
some diﬀerences in characteristics to those participants in
hospitals, public health clinics, and the general community.
Secondly, the study population did not include PTB suspects
who were younger than 18 years, and 85 patients were
excluded due to missing medical records. It is possible
that some in both groups had active TB. Thirdly, accuracy
of interpretation of routinely oﬀered TB diagnostic tests
(sputum smear and chest radiographs) depends on the skills
and experience of the attending clinician. Interpretation of
these tests is often subjective and prone to error; hence
some of the results might have been incorrect. Fourthly,
some patients in this cohort 42/630 (6.7%) did not return
their sputum jars (lost to follow-up) and, therefore, were
not investigated for AFB. It is possible that some of these
patients had TB or had died of TB. Lastly we did not have
data documenting the duration of TB symptoms prior to
presenting at a health facility, therefore we would not know
length of diagnosis delay attributed to TB patient’s health
seeking behaviour. The exclusion of patients who were lost-
to-follow-up and the definition of delay from presentation
at health system, rather than start of symptoms, make these
findings conservative as the true proportion of patients
experiencing diagnosis delays would be higher than what has
been reported in this study.
5. Conclusion
The diagnostic delays for PTB demonstrated in this study,
as well as the diﬃculty of diagnosing TB in HIV-infected
patients, point to the need for improved screening of TB
suspects in ART clinics. Novel TB diagnostic methods such
as Gene-Xpert, which are rapid, highly sensitive, and specific,
should be promoted in primary health care facilities in order
to ensure the timely diagnosis of PTB.
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